TY - JOUR AU - Guyatt, G. H. AU - Akl, E. A. AU - Crowther, M. AU - Gutterman, D. D. AU - Schuünemann, H. J. PY - 2012 DA - 2012// TI - Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 UR - https://doi.org/10.1378/chest.1412S3 DO - 10.1378/chest.1412S3 ID - Guyatt2012 ER - TY - JOUR AU - Harenberg, J. AU - Walenga, J. AU - Torri, G. PY - 2013 DA - 2013// TI - Update of the recommendations on biosimilar low-molecular-weight heparins from the scientific Subcommittee on Control of Anticoagulation of the International Society on thrombosis and Haemostasis JO - J Thromb Haemost VL - 11 UR - https://doi.org/10.1111/jth.12269 DO - 10.1111/jth.12269 ID - Harenberg2013 ER - TY - JOUR AU - Harenberg, J. AU - Cimminiello, C. AU - Agnelli, G. PY - 2016 DA - 2016// TI - Biosimilars of low-molecular-weight heparin products: fostering competition or reducing ‘biodiversity’? JO - J Thromb Haemost VL - 14 UR - https://doi.org/10.1111/jth.13237 DO - 10.1111/jth.13237 ID - Harenberg2016 ER - TY - JOUR AU - Harenberg, J. PY - 2011 DA - 2011// TI - Differences of present recommendations and guidelines for generic low-molecular-weight heparins: is there room for harmonization JO - Clin Appl Thromb Hemost VL - 17 UR - https://doi.org/10.1177/1076029610392216 DO - 10.1177/1076029610392216 ID - Harenberg2011 ER - TY - STD TI - Guidelines on clinical and non-clinical development of medicinal products containing low-molecular-weight heparins. European Medical Agency. EMEA/CHMP/BMWP/118264/2007. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003927.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003927.pdf ID - ref5 ER - TY - JOUR AU - Harenberg, J. AU - Kakkar, A. AU - Bergqvist, D. PY - 2009 DA - 2009// TI - Recommendations on biosimilar low-molecular-weight heparins JO - J Thromb Haemost VL - 7 UR - https://doi.org/10.1111/j.1538-7836.2009.03349.x DO - 10.1111/j.1538-7836.2009.03349.x ID - Harenberg2009 ER - TY - JOUR AU - Kalodiki, E. AU - Fareed, J. AU - Tapson, W. F. PY - 2010 DA - 2010// TI - A consensus conference on complex biologics and low molecular weight heparin JO - Int Angiol VL - 29 ID - Kalodiki2010 ER - TY - STD TI - FDA News Release, July 23, 2010. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm220092.htm. Accessed 2 Dec 2016. UR - http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm220092.htm ID - ref8 ER - TY - STD TI - FDA’s response to the citizen petition. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220018.htm. Accessed 2 Dec 2016. UR - http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220018.htm ID - ref9 ER - TY - STD TI - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues. EMEA/CHMP/BWP/49348/2005. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003953.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003953.pdf ID - ref10 ER - TY - STD TI - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (revision 1). EMA/CHMP/BWP/247713/2012. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/06/WC500167838.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/06/WC500167838.pdf ID - ref11 ER - TY - STD TI - Concept paper on the revision of the guideline on nonclinical and clinical development of similar biological medicinal products containing low-molecular-weight heparins. European Medical Agency. EMA/CHMP/BMWP/522386/2011 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/07/WC500109588.pdf. Accessed December 2, 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/07/WC500109588.pdf ID - ref12 ER - TY - STD TI - Guideline on similar biological medicinal products. European Medical Agency. CHMP/437/04 Rev 1. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500176768.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500176768.pdf ID - ref13 ER - TY - STD TI - Assessment report. Thorinane. International non-proprietary name: enoxaparin sodium. Procedure No. EMEA/H/C/003795/0000. EMA/536972/2016. Committee for Medicinal Products for Human Use (CHMP). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/003795/WC500215281.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/003795/WC500215281.pdf ID - ref14 ER - TY - STD TI - Assessment report. Inhixa. International non-proprietary name: enoxaparin sodium. Procedure No. EMEA/H/C/004264/0000. EMA/536977/2016. Committee for Medicinal Products for Human Use (CHMP). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004264/WC500215211.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004264/WC500215211.pdf ID - ref15 ER - TY - STD TI - Guideline on similar biological medicinal products containing Biotechnology-derived proteins as active substance: Non-clinical and clinical issues. EMEA/CHMP/BMWP/42832/2005. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003920.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003920.pdf ID - ref16 ER - TY - JOUR AU - Schwartz, L. B. PY - 2008 DA - 2008// TI - Heparin comes clean JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMe0803599 DO - 10.1056/NEJMe0803599 ID - Schwartz2008 ER - TY - JOUR AU - Grampp, G. AU - Bonafede, M. AU - Felix, T. PY - 2015 DA - 2015// TI - Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars JO - Expert Opin Drug Saf VL - 14 UR - https://doi.org/10.1517/14740338.2015.1001364 DO - 10.1517/14740338.2015.1001364 ID - Grampp2015 ER - TY - STD TI - Guideline on non-clinical and clinical development of similar biological medicinal products containing low-molecular-weight-heparins. European Medical Agency. EMEA/CHMP/BMWP/118264/2007 Rev. 1. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/11/WC500217126.pdf. Accessed 2 Dec 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/11/WC500217126.pdf ID - ref19 ER - TY - JOUR AU - Faccin, F. AU - Tebbey, P. AU - Alexander, E. PY - 2016 DA - 2016// TI - The design of clinical trials to support the switching and alternation of biosimilars JO - Expert Opin Biol Ther VL - 16 UR - https://doi.org/10.1080/14712598.2017.1238454 DO - 10.1080/14712598.2017.1238454 ID - Faccin2016 ER -